Intermittent Fasting Clinical Trial
Official title:
The Effect of Intermittent Fasting on Acute Subconcussive Head Impacts
NCT number | NCT05236127 |
Other study ID # | 13076 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 23, 2022 |
Est. completion date | August 31, 2022 |
Verified date | September 2023 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to examine the effect of intermittent fasting on the acute neural responses to subconcussive head impacts. The study is designed to identify the effects of 20 controlled soccer headings in college-aged soccer players in one of four groups (fasted, pre-fasted, post-fasted, or control) through the use of neural-injury blood biomarkers, magnetic resonance spectroscopy, functional, and diffusion MRI, and ocular-motor function across 4 acute time points. The central hypothesis is that the neuronal structural, physiological, and functional impairments from the subconussive head impacts will be lessened by intermittent fasting either before or after the soccer headings. The neural-injury blood biomarkers neurofilament light (NfL), glial fibrillary acidic protein (GFAP), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), and Tau will be measured in serum, with the hypothesis that fasting prior to the 20 soccer headings will result in a decreased heightened response compared to the post-heading fasted group and the controls. It is also hypothesized that repetitive subconcussive head impacts will impair neurocognitive function, as measured by regional changes in fMRI activation during a working memory task in the fasted groups. Twenty headings will significantly alter fMRI activation in the fasted groups from baseline. This impairment will not be observed in the control group. White matter microstructure will be measured by diffusion imaging metrics, with the hypothesis that 20 soccer headings will significantly disrupt microstructure in the fasted groups compared to baseline, but not in the control group. The study will also assess neuro-opthalmologic function as measured by the King-Devick test (KDT) and oculomotor function as measured by near-point-of-convergence (NPC) in response to subconcussive head impacts. The hypothesis is that NPC performance will be significantly impaired for longer than 24 hours in all the groups, but this impairment will be greater in the control group, and that the learning curve and expected improvement of KDT will be significantly blunted in both groups, with a display worsening in the control group.
Status | Completed |
Enrollment | 40 |
Est. completion date | August 31, 2022 |
Est. primary completion date | August 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility | Inclusion Criteria: - 18-30 years of age - At least three years of soccer heading experience Exclusion Criteria: - Diabetes - Any current intermittent fasting or in the last 3-6 months - Any head or eye injury 12 months prior to the study - Any neurological disorders (e.g., seizures, closed head injuries with prolonged loss of consciousness (> 15 minutes), history of stroke, spinal cord/surgery) - History of vestibular, ocular, or vision dysfunction - Any injury that would prohibit the performance of soccer headings - A history of eating disorder - Any brain implants or recent surgeries with metal implants that prohibit undergoing an MRI - Currently taking any medications affecting appetite - Pregnant - HIV |
Country | Name | City | State |
---|---|---|---|
United States | Indiana University School of Public Health | Bloomington | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University |
United States,
Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous AG 3rd, Leeuwenburgh C, Mattson MP. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity (Silver Spring). 2018 Feb;26(2):254-268. doi: 10.1002/oby.22065. Epub 2017 Oct 31. — View Citation
Kawata K, Steinfeldt JA, Huibregtse ME, Nowak MK, Macy JT, Kercher K, Rettke DJ, Shin A, Chen Z, Ejima K, Newman SD, Cheng H. Association Between Proteomic Blood Biomarkers and DTI/NODDI Metrics in Adolescent Football Players: A Pilot Study. Front Neurol. 2020 Nov 16;11:581781. doi: 10.3389/fneur.2020.581781. eCollection 2020. — View Citation
Koerte IK, Lin AP, Muehlmann M, Merugumala S, Liao H, Starr T, Kaufmann D, Mayinger M, Steffinger D, Fisch B, Karch S, Heinen F, Ertl-Wagner B, Reiser M, Stern RA, Zafonte R, Shenton ME. Altered Neurochemistry in Former Professional Soccer Players without a History of Concussion. J Neurotrauma. 2015 Sep 1;32(17):1287-93. doi: 10.1089/neu.2014.3715. Epub 2015 May 14. — View Citation
Nowak MK, Bevilacqua ZW, Ejima K, Huibregtse ME, Chen Z, Mickleborough TD, Newman SD, Kawata K. Neuro-Ophthalmologic Response to Repetitive Subconcussive Head Impacts: A Randomized Clinical Trial. JAMA Ophthalmol. 2020 Apr 1;138(4):350-357. doi: 10.1001/jamaophthalmol.2019.6128. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in brain-derived blood biomarkers from day 4 to day 5 and group differences | Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum samples will be aliquoted and stored at -80 degree celsius until analysis.
Serum samples will be assayed for neurofilament-light (NfL) and glial fibrillary acidic protein (GFAP). All expression levels in pg/mL. |
Blood samples will be collected at day 4 (prior to heading) and day 5 (24 hours post-heading). | |
Primary | Change in brain-derived blood biomarkers from day 4 to day 7 and group differences | Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum samples will be aliquoted and stored at -80 degree celsius until analysis.
Serum samples will be assayed for neurofilament-light (NfL) and glial fibrillary acidic protein (GFAP). All expression levels in pg/mL. |
Blood samples will be collected at day 4 (prior to heading) and day 7 (72 hours post heading). | |
Primary | Change in regional fMRI activation during the memory task from day 4 to day 5 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to collect fMRI images while a working memory task is administered.
The task based fMRI protocol consists of N-back verbal working memory and a resting state task. |
fMRI procedures will be performed on day 4 (prior to heading) and day 5 (24 hours post-heading) | |
Primary | Change in regional fMRI activation during the memory task from day 4 to day 7 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to collect fMRI images while a working memory task is administered.
The task based fMRI protocol consists of N-back verbal working memory and a resting state task. |
fMRI procedures will be performed on day 4 (prior to heading) and day 7 (72 hours post-heading) | |
Primary | Change in regional resting state functional connectivity from day 4 to day 5 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to collect resting state functional connectivity. | fMRI procedures will be performed day 4 (prior to heading) and day 5 (24 hours post-heading). | |
Primary | Change in regional resting state functional connectivity from day 4 to day 7 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to collect resting state functional connectivity. | fMRI procedures will be performed day 4 (prior to heading) and day 7 (72 hours post-heading). | |
Primary | Change in axonal microstructure from day 4 to day 5 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to assess changes in diffusion metrics.
Whole-brain Diffusion tensor imaging (DTI) will be performed with a multi-slice single-shot spin echo echoplanar pulse sequence (echo time [TE] = 81 ms; repetition time [TR] = 9 s) using 64 diffusion-encoding directions, isotopically distributed over the surface of a sphere with electrostatic repulsion. |
MRI procedures will be performed day 4 (prior to heading) and day 5 (24 hours post-heading). | |
Primary | Change in axonal microstructure from day 4 to day 7 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to assess changes in diffusion metrics.
Whole-brain Diffusion tensor imaging (DTI) will be performed with a multi-slice single-shot spin echo echoplanar pulse sequence (echo time [TE] = 81 ms; repetition time [TR] = 9 s) using 64 diffusion-encoding directions, isotopically distributed over the surface of a sphere with electrostatic repulsion. |
MRI procedures will be performed day 4 (prior to heading) and day 7 (72 hours post-heading). | |
Primary | Change in a panel of metabolites from day 4 to day 5 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to assess changes in neurometabolic metrics. The metabolic panel includes the following: N-Acetylaspartate (NAA), Glutamine/Glutamate (Glx), Myo-Inositol (mI), Choline (Cho), and Creatine (Cr). | MRI procedures will be performed day 4 (prior to heading) and day 5 (24 hours post-heading). | |
Primary | Change in a panel of metabolites from day 4 to day 7 and group differences | A standardized MRI protocol acquired on a Siemens TIM Trio scanner, equipped with a 64 channel phased array head radiofrequency coil will be used to assess changes in neurometabolic metrics. The metabolic panel includes the following: N-Acetylaspartate (NAA), Glutamine/Glutamate (Glx), Myo-Inositol (mI), Choline (Cho), and Creatine (Cr). | MRI procedures will be performed day 4 (prior to heading) and day 7 (72 hours post-heading). | |
Secondary | Change in near point of convergence from day 0 to day 4 and group differences | Participants will undergo a brief test of near-point of convergence | Near point of convergence will be assessed at day 0 and day 4 (prior to heading). | |
Secondary | Change in near point of convergence from day 4 to day 7 and group differences | Participants will undergo a brief test of near-point of convergence | Near point of convergence will be assessed at day 4 (prior to heading) and day 7 (72 hours post-heading). | |
Secondary | Change in King Devick performance from day 0 to day 4 and group differences | Participants will undergo the King-Devick Test--a brief assessment of saccadic eye movements, attention, and visual and language processing | King Devick performance will be assessed at day 0 and day 4 (prior to heading) | |
Secondary | Change in King Devick performance from day 4 to day 7 and group differences | Participants will undergo the King-Devick Test--a brief assessment of saccadic eye movements, attention, and visual and language processing | King Devick performance will be assessed at day 4 (prior to heading) and day 7 (72 hours post-heading). | |
Secondary | Change in brain-derived blood biomarkers from day 0 to day 4 and group differences | Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum samples will be aliquoted and stored at -80 degree celsius until analysis.
Serum samples will be assayed for neurofilament-light (NfL) and glial fibrillary acidic protein (GFAP). All expression levels in pg/mL. |
Blood samples will be collected at day 0 and day 4 (prior to heading). | |
Secondary | Change in brain-derived blood biomarkers from day day 0 to day 5 and group differences | Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum samples will be aliquoted and stored at -80 degree celsius until analysis.
Serum samples will be assayed for neurofilament-light (NfL) and glial fibrillary acidic protein (GFAP). All expression levels in pg/mL. |
Blood samples will be collected at day 0 and day 5 (24 hours post heading). | |
Secondary | Change in brain-derived blood biomarkers from day day 0 to day 7 and group differences | Blood samples will be collected and centrifuged at 1500 x g for ten minutes at 4 degree celsius. Serum samples will be aliquoted and stored at -80 degree celsius until analysis.
Serum samples will be assayed for neurofilament-light (NfL) and glial fibrillary acidic protein (GFAP). All expression levels in pg/mL. |
Blood samples will be collected at day 0 and day 7 (72 hours post heading). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04647149 -
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
|
N/A | |
Completed |
NCT04953650 -
Intermittent Fasting Towards Elevated Blood Pressure
|
N/A | |
Active, not recruiting |
NCT05290233 -
Time Restricted Eating Plus Exercise for Weight Management
|
N/A | |
Completed |
NCT04404413 -
High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women
|
N/A | |
Recruiting |
NCT05558423 -
ZOE Health Study: The Intermittent Fasting Study
|
N/A | |
Completed |
NCT02770313 -
Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction
|
N/A | |
Active, not recruiting |
NCT05344066 -
Manchester Intermittent Diet in Gestational Diabetes Acceptability Study
|
N/A | |
Not yet recruiting |
NCT06330610 -
Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit
|
N/A | |
Not yet recruiting |
NCT06299020 -
Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency
|
N/A | |
Recruiting |
NCT03789409 -
Intermittent Fasting Following Acute Ischemic Stroke
|
N/A | |
Not yet recruiting |
NCT06302231 -
Effects of Time-restricted Eating and Aerobic Exercise Training in Women With Overweight and Obesity
|
N/A | |
Recruiting |
NCT05760339 -
Intermittent Fasting Versus Carbohydrate Drinks Before Surgery
|
N/A | |
Recruiting |
NCT06429124 -
Time Restricted Eating in Alzheimer's Disease (TREAD)
|
N/A | |
Enrolling by invitation |
NCT06105372 -
Ramadan Fasting, Microbiota and FABP4
|
||
Completed |
NCT04732130 -
Monitoring During Different Intermittent Fasting Protocols in Non-Obese Adults
|
N/A | |
Completed |
NCT05422391 -
The Acute Effects of Caloric Restriction on Anthropometrics, Metabolism, and Cardiovascular Health in Overweight Adults
|
N/A | |
Recruiting |
NCT05136313 -
Healthy vs Unhealthy Obesity: Mehanistic Insights and Effects of Time-Restricted Eating
|
N/A | |
Not yet recruiting |
NCT06323889 -
Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
|
N/A | |
Completed |
NCT01378208 -
How Often Should We Eat
|
N/A | |
Recruiting |
NCT04873648 -
Effect of Fasting and Calorie-Restricted Diets on Dopamine and Serotonin Levels Among Obese Women With BED and FA
|
N/A |